Abstract
Efficacious, potent, and at the same time nontoxic macromolecular prodrugs of ribavirin are designed taking advantage over prodrug activation by the intracellular milieu. Activity of these prodrugs is illustrated in the cells hosting hepatitis C virus replication and also in the cells implicated in the inflammatory response to the viral infection.
Keywords:
drug delivery; hepatitis C virus; polymers; prodrugs.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antiviral Agents* / chemical synthesis
-
Antiviral Agents* / chemistry
-
Antiviral Agents* / pharmacology
-
Cell Line
-
Gene Expression Regulation, Viral / drug effects*
-
Genome, Viral*
-
Hepacivirus / genetics
-
Hepacivirus / metabolism*
-
Hepatitis C / drug therapy*
-
Hepatitis C / genetics
-
Hepatitis C / metabolism
-
Hepatitis C / pathology
-
Humans
-
Polymethacrylic Acids* / chemical synthesis
-
Polymethacrylic Acids* / chemistry
-
Polymethacrylic Acids* / pharmacology
-
Prodrugs* / chemical synthesis
-
Prodrugs* / chemistry
-
Prodrugs* / pharmacology
-
Ribavirin* / analogs & derivatives
-
Ribavirin* / chemical synthesis
-
Ribavirin* / chemistry
-
Ribavirin* / pharmacology
Substances
-
Antiviral Agents
-
Polymethacrylic Acids
-
Prodrugs
-
polymethacrylic acid
-
Ribavirin